Previous 10 | Next 10 |
Cerus Corporation (Nasdaq:CERS) announced today a new corporate branding campaign building upon the Company’s leadership position in helping to safeguard the world’s blood supply and the planned relocation of its corporate offices to a new facility in Concord California. The ne...
Cerus Corporation (Nasdaq: CERS) today announced that the FDA has issued a final guidance document recommending protocols for reducing the risk of transfusion transmitted Babesiosis. In 15 Babesiosis endemic states, treating donated blood components with the INTERCEPT Blood System is a recog...
Cerus Corporation (CERS) Q1 2019 Earnings Conference Call May 7, 2019 16:30 ET Company Participants Tim Lee - Director, IR Obi Greenman - President & CEO Carol Moore - SVP, Regulatory Affairs & Quality Kevin Green - CFO Vivek Jayaraman - Chief Commercial Officer Co...
Cerus (NASDAQ: CERS ): Q1 GAAP EPS of -$0.14 misses by $0.03 . More news on: Cerus Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2019. Recent developments and highlights include: Total first quarter revenue of $22.0 million Record quarterly product revenue of $17.5 million, a 29% increase compared to ...
Cerus (NASDAQ: CERS ) is scheduled to announce Q1 earnings results on Tuesday, May 7th, after market close. The consensus EPS Estimate is -$0.11 (flat Y/Y) and the consensus Revenue Estimate is $15.31M (+12.9% Y/Y). Over the last 1 year, cers has beaten EPS estimates 100% of the time...
Cerus Corporation (Nasdaq:CERS) announced today that its first quarter 2019 results will be released on Tuesday, May 7, 2019, after the close of the stock market. The company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Comp...
Cerus (NASDAQ: CERS ) has closed a new debt facility with MidCap Financial, consisting of a $70M term loan and a $5M credit revolver expandable up to $20M. More news on: Cerus Corporation, Healthcare stocks news, Read more ...
Cerus Corporation (Nasdaq: CERS) today announced the closing of a new debt facility with MidCap Financial (MidCap) which is expandable up to $90 million. The debt facility consists of a staged $70 million term loan and a $5 million revolving line of credit, expandable up to $20 million. ...
Cerus Corporation (Nasdaq: CERS) today announced the appointment of Jami Nachtsheim to its Board of Directors. Ms. Nachtsheim currently serves on the Board at Intuitive Surgical, the global market leader in robotic-assisted minimally invasive surgical systems. Ms. Nachtsheim brings nearly fo...
News, Short Squeeze, Breakout and More Instantly...
Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2024 financial results will be released on Thursday, August 1, 2024, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discu...
Cerus Corporation (Nasdaq: CERS) today announced the appointment of Dean Gregory to its Board of Directors. Mr. Gregory has a 30+-year career as a leader in the global blood transfusion and cell therapy industry, with broad experience across commercialization, product development, supply chain an...
Symposium and Abstracts Highlight Data from Real-world Implementation and Utilization of INTERCEPT Platelets and Plasma as well as from Red Blood Cell and LED Illuminator Programs Cerus Corporation (Nasdaq:CERS) today announced a lunch symposium and selection of abstracts at the 38 th...